Works matching IS 14611457 AND DT 2012 AND VI 15 AND IP 4

Results: 24

Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 449, doi. 10.1017/S1461145711000745

By:

Konstantinidis, A.;
Papageorgiou, K.;
Grohmann, R.;
Horvath, A.;
Engel, R.;
Kasper, S.

Publication type:

Article

Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 435, doi. 10.1017/S1461145711000691

By:

Underwood, Mark D.;
Kassir, Suham A.;
Bakalian, Mihran J.;
Galfalvy, Hanga;
Mann, J. John;
Arango, Victoria

Publication type:

Article

D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson’s disease.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 543, doi. 10.1017/S1461145711001015

By:

Gelfin, Evgenia;
Kaufman, Yakir;
Korn-Lubetzki, Isabelle;
Bloch, Boaz;
Kremer, Ilana;
Javitt, Daniel C.;
Heresco-Levy, Uriel

Publication type:

Article

Vagus nerve stimulation enhances perforant path-CA3 synaptic transmission via the activation of β-adrenergic receptors and the locus coeruleus.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 523, doi. 10.1017/S1461145711000708

By:

Huilian Shen;
Yuta Fuchino;
Daisuke Miyamoto;
Hiroshi Nomura;
Norio Matsuki

Publication type:

Article

Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca2+ influx of NMDA receptors.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 497, doi. 10.1017/S1461145711000654

By:

Lin Li;
Rong Yang;
Kaiyue Sun;
Yinyang Bai;
Zhuo Zhang;
Libin Zhou;
Zhi Qi;
Jianhua Qi;
Ling Chen

Publication type:

Article

Dopamine in the hippocampus is cleared by the norepinephrine transporter.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 531, doi. 10.1017/S1461145711000812

By:

Borgkvist, Anders;
Malmlöf, Torun;
Feltmann, Kristin;
Lindskog, Maria;
Schilström, Björn

Publication type:

Article

DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 459, doi. 10.1017/S1461145711000903

By:

Alkelai, Anna;
Lupoli, Sara;
Greenbaum, Lior;
Kohn, Yoav;
Kanyas-Sarner, Kyra;
Ben-Asher, Edna;
Lancet, Doron;
Macciardi, Fabio;
Lerer, Bernard

Publication type:

Article

Modulation of haloperidol-induced patterns of the transcription factor Nur77 and Nor-1 expression by serotonergic and adrenergic drugs in the mouse brain.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 509, doi. 10.1017/S1461145711000630

By:

Maheux, Jérôme;
Vuillier, Laura;
Mahfouz, Mylène;
Rouillard, Claude;
Lévesque, Daniel

Publication type:

Article

Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 485, doi. 10.1017/S1461145711000599

By:

Nelson, Andrew J. D.;
Thur, Karen E.;
Marsden, Charles A.;
Cassaday, Helen J.

Publication type:

Article

Blockade of dopamine D3 but not D2 receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 471, doi. 10.1017/S1461145711000435

By:

Watson, David J. G.;
Marsden, Charles A.;
Millan, Mark J.;
Fone, Kevin C. F.

Publication type:

Article

An enhancement of the firing activity of dopamine neurons as a common denominator of antidepressant treatments?

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 551, doi. 10.1017/S1461145711001362

By:

Chenu, Franck;
Ghanbari, Ramez;
El Mansari, Mostafa;
Blier, Pierre

Publication type:

Article

mTOR activation is required for the antidepressant effects of mGluR2/3 blockade.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 429, doi. 10.1017/S1461145711001702

By:

Dwyer, Jason M.;
Lepack, Ashley E.;
Duman, Ronald S.

Publication type:

Article

PNP volume 15 issue 5 Cover and Back matter.

Published in:: 2012
Publication type:: Table of Contents

PNP volume 15 issue 5 Cover and Front matter.

Published in:: International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. f1, doi. 10.1017/S1461145712000430
Publication type:: Article

Auditory event-related potentials (P3) and cognitive changes induced by frontal direct current stimulation in alcoholics according to Lesch alcoholism typology.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 601, doi. 10.1017/S1461145711001040

By:

Nakamura-Palacios, Ester Miyuki;
de Almeida Benevides, Marcelo Campos;
da Penha Zago-Gomes, Maria;
de Oliveira, Roney Welinton Dias;
de Vasconcellos, Vítor Fiorin;
de Castro, Lais Norberto Passos;
da Silva, Morgana Croce;
Ramos, Paula Amorim;
Fregni, Felipe

Publication type:

Article

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 589, doi. 10.1017/S1461145711001027

By:

Alvarez, Enric;
Perez, Victor;
Dragheim, Marianne;
Loft, Henrik;
Artigas, Francesc

Publication type:

Article

Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 669, doi. 10.1017/S1461145711000940

By:

Melas, Philippe A.;
Rogdaki, Maria;
Lennartsson, Andreas;
Björk, Karl;
Qi, Hongshi;
Witasp, Anna;
Werme, Martin;
Wegener, Gregers;
Mathé, Aleksander A.;
Svenningsson, Per;
Lavebratt, Catharina

Publication type:

Article

Rapid-acting antidepressant strategies: mechanisms of action.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 695, doi. 10.1017/S1461145711000927

By:

Bunney, Blynn G.;
Bunney, William E.

Publication type:

Article

Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 573, doi. 10.1017/S1461145711000861

By:

Gil-Pisa, Itziar;
Munarriz-Cuezva, Eva;
Ramos-Miguel, Alfredo;
Urigüen, Leyre;
Meana, J. Javier;
García-Sevilla, Jesús A.

Publication type:

Article

Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 657, doi. 10.1017/S1461145711000848

By:

Jones, Nigel C.;
Reddy, Maya;
Anderson, Paul;
Salzberg, Michael R.;
O'Brien, Terence J.;
Pinault, Didier

Publication type:

Article

Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 645, doi. 10.1017/S1461145711000824

By:

Carboni, Lucia;
Negri, Michele;
Michielin, Francesca;
Bertani, Simone;
Fratte, Sonia Delle;
Oliosi, Beatrice;
Cavanni, Paolo

Publication type:

Article

Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 631, doi. 10.1017/S1461145711000782

By:

Pascual-Brazo, Jesús;
Castro, Elena;
Díaz, Álvaro;
Valdizán, Elsa M.;
Pilar-Cuéllar, Fuencisla;
Vidal, Rebeca;
Treceño, Begoña;
Pazos, Ángel

Publication type:

Article

Mood dysregulation and stabilization: perspectives from emotional cognitive neuroscience.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 681, doi. 10.1017/S1461145711000757

By:

Yamawaki, Shigeto;
Okada, Go;
Okamoto, Yasumasa;
Liberzon, Israel

Publication type:

Article

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 617, doi. 10.1017/S1461145711000733

By:

Serres, Florence;
Millan, Mark J.;
Sharp, Trevor

Publication type:

Article

Works matching IS 14611457 AND DT 2012 AND VI 15 AND IP 4

Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program.

Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson’s disease.

Vagus nerve stimulation enhances perforant path-CA3 synaptic transmission via the activation of β-adrenergic receptors and the locus coeruleus.

Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca<sup>2+</sup> influx of NMDA receptors.

Dopamine in the hippocampus is cleared by the norepinephrine transporter.

DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population.

Modulation of haloperidol-induced patterns of the transcription factor Nur77 and Nor-1 expression by serotonergic and adrenergic drugs in the mouse brain.

Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.

Blockade of dopamine D<sub>3</sub> but not D<sub>2</sub> receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.

An enhancement of the firing activity of dopamine neurons as a common denominator of antidepressant treatments?

mTOR activation is required for the antidepressant effects of mGluR<sub>2/3</sub> blockade.

PNP volume 15 issue 5 Cover and Back matter.

PNP volume 15 issue 5 Cover and Front matter.

Auditory event-related potentials (P3) and cognitive changes induced by frontal direct current stimulation in alcoholics according to Lesch alcoholism typology.

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.

Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.

Rapid-acting antidepressant strategies: mechanisms of action.

Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment.

Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power.

Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release.

Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333.

Mood dysregulation and stabilization: perspectives from emotional cognitive neuroscience.

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.